Conclusion
This article highlights cystic fibrosis patients are at risk of
drug-drug interactions with cardiovascular medications. Therefore, this
article emphasises the need for physicians to consider cardiovascular
drug-drug interactions when planning the therapeutic regimen for CF
exacerbation.